Fidelity Investments
BOLD

Fidelity Investments’s Audentes Therapeutics, Inc BOLD Stock Holding History

Fidelity Investments’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,401,119
Closed -$39.4M – 4487
2019
Q3 		$39.4M Sell
1,401,119
-147,244
-10% -$5.03M ﹤0.01% 1289
2019
Q2 		$58.6M Sell
1,548,363
-1,091,447
-41% -$41.9M 0.01% 1142
2019
Q1 		$103M Sell
2,639,810
-512,074
-16% -$14.7M 0.01% 893
2018
Q4 		$67.2M Sell
3,151,884
-744,507
-19% -$19.2M 0.01% 1032
2018
Q3 		$154M Sell
3,896,391
-435,453
-10% -$16.2M 0.02% 768
2018
Q2 		$166M Sell
4,331,844
-703,223
-14% -$26M 0.02% 736
2018
Q1 		$151M Buy
5,035,067
+623,434
+14% +$21.1M 0.02% 800
2017
Q4 		$138M Buy
4,411,633
+1,139,035
+35% +$31.3M 0.02% 852
2017
Q3 		$91.7M Buy
3,272,598
+2,951,598
+920% +$64.1M 0.01% 1010
2017
Q2 		$6.14M Sell
321,000
-10,000
-3% -$160K ﹤0.01% 2110
2017
Q1 		$5.64M Sell
331,000
-19,000
-5% -$307K ﹤0.01% 2148
2016
Q4 		$6.39M Hold
350,000
– – ﹤0.01% 2115
2016
Q3 		$6.23M Buy
+350,000
New +$5.31M ﹤0.01% 2141

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Fidelity Investments's BOLD Position: Q4 2019 in Review

Fidelity Investments sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 1,401,119 shares — an estimated $39.4M sold.

Fidelity Investments first reported a position in BOLD in Q3 2016 and held it in 13 quarters. The position peaked at $166M in Q2 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Fidelity Investments reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Fidelity Investments sold 1,401,119 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $39.4M.
  • Fidelity Investments first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 13 quarters.
  • Fidelity Investments's Audentes Therapeutics, Inc position peaked at $166M in Q2 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.